🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans

Michael W. Freeman

Stock Analyst at Raymond James

(1.66)
# 3,558
Out of 5,162 analysts
46
Total ratings
38.2%
Success rate
0.2%
Average return

Stocks Rated by Michael W. Freeman

Vitalhub Corp.
Nov 17, 2026
Maintained: Buy
Price Target: $10.50
Current: $7.00
Upside: +50.00%
Profound Medical Corp.
Aug 7, 2026
Reiterated: Buy
Price Target: n/a
Current: $10.60
Upside: -
WELL Health Technologies Corp.
Aug 7, 2026
Reiterated: Buy
Price Target: n/a
Current: $3.84
Upside: -
Apotex Health Corp.
Jul 6, 2026
Initiated Coverage: Buy
Price Target: $36.00
Current: $39.44
Upside: -8.72%
Healwell AI Inc.
Mar 25, 2026
Reiterated: Buy
Price Target: $3.00 → $2.50
Current: $0.60
Upside: +316.67%
HLS Therapeutics Inc.
Nov 18, 2025
Reiterated: Buy
Price Target: $6.00 → $7.00
Current: $3.71
Upside: n/a
Medexus Pharmaceuticals Inc.
Aug 14, 2025
Reiterated: Buy
Price Target: $8.00
Current: $5.43
Upside: n/a
Bausch Health Companies Inc.
Aug 5, 2025
Reiterated: Hold
Price Target: $11.35
Current: $11.91
Upside: n/a
Knight Therapeutics Inc.
Mar 12, 2025
Reiterated: Buy
Price Target: $8.00
Current: $12.06
Upside: n/a
Perimeter Medical Imaging AI, Inc.
Nov 18, 2024
Upgraded: Buy
Price Target: $1.50
Current: $0.15
Upside: n/a